Skip to content

SK Bioscience

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2021

    Novavax and SK Bioscience expand vaccine collaboration for South Korea

    Novavax and SK Bioscience expanded their existing manufacturing arrangement for NVX-CoV2373. The agreement provides for technology transfer and adjuvant supply, while SK Bioscience finalized an advance purchase agreement with the Korean government to supply 40 million doses beginning in 2021.